| 2012-02 |
Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy |
Journal of Clinical Oncology. 2012 Feb;30(4):613. |
|
| 2021-05 |
Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC) |
Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 4090. |
|
| 2010-05 |
Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors |
Journal of Clinical Oncology. 2010 May;28(15):Abstract Number e13024. |
|
| 2015-03 |
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients |
Cancer Chemotherapy and Pharmacology. 2015 Mar;75(3):579-586. |
 |
| 2002 |
A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer |
Oncology. 2002;63(3):239-247. |
|
| 2016-02 |
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC) |
Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369. |
|
| 2013-05 |
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine |
Vaccine. 2013 May;31(20):2471-2476. |
|
| 2006-03 |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer |
Journal of Gastroenterology and Hepatology. 2006 Mar;21(3):531-536. |
|
| 2008-05 |
Phase I/II study of capecitabine and PHY906 in hepatocellular carcinoma |
Journal of Clinical Oncology. 2008 May;26(15 Suppl):Abstract number 4610. |
|
| 2018-05 |
A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers |
Journal of Clinical Oncology. 2018 May;36(15, Suppl. S):Meeting Abstract 2556. |
|
| 2011-08-17 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan |
Cancer Chemotherapy and Pharmacology. 2011 Aug 17;67(6):1281-1289. |
|
| 2002-05 |
Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients |
Cancer Chemotherapy and Pharmacology. 2002 May;49(5):425-428. |
|
| 2014-07 |
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer |
Oncology. 2014 Jul;87(2):104-113. |
|
| 2007-05 |
Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy |
Cancer. 2007 May;109(9):1821-1828. |
|
| 2006-02 |
A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly |
Journal of Thoracic Oncology. 2006 Feb;1(2):141-145. |
|
| 2008-08 |
A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly |
Lung Cancer. 2008 Aug;61(2):214-219. |
|
| 2008-01 |
Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy |
Lung Cancer. 2008 Jan;59(1):64-68. |
|
| 2009-05-20 |
Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged >= 70 years in Taiwan |
Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 8051. |
|
| 2017-09 |
A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients |
Scientific Reports. 2017 Sep;7:Article number 11253. |
|
| 2018-01 |
Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma |
Journal of Clinical Oncology. 2018 Jan;36(3):276-282. |
|
| 2009-11 |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer |
Cancer Chemotherapy and Pharmacology. 2009 Nov;64(6):1173-1179. |
|
| 2012-02 |
Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma |
International Journal of Radiation Oncology, Biology, Physics. 2012 Feb;82(2):817-825. |
|
| 2002-10 |
Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy |
American Journal of Clinical Oncology. 2002 Oct;25(5):509-512. |
|
| 2003-02 |
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel |
Lung Cancer. 2003 Feb;39(2):209-214. |
|
| 2000 |
Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT) |
Annals of Oncology. 2000;11:522P. |
|
| 2003-12 |
Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy |
American Journal of Clinical Oncology. 2003 Dec;26(6):567-570. |
|
| 2006-01 |
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma |
Head and Neck. 2006 Jan;28(1):74-80. |
|
| 2009-05-20 |
A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study |
Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15562. |
|
| 1997-04 |
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer |
Japanese Journal of Clinical Oncology. 1997 Apr;27(2):76-79. |
|
| 2011-09 |
Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers |
European Journal of Cancer. 2011 Sep;47(Suppl 1):S467. |
|
| 2011-09-23 |
A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou |
European Journal of Cancer. 2011 Sep 23;47:S547-S548. |
|
| 2000-08 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy |
Lung Cancer. 2000 Aug;29(2):139-146. |
|
| 2010-10 |
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer |
British Journal of Cancer. 2010 Oct;103(9):1343-1348. |
|
| 2011-02 |
Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers |
Journal of Clinical Oncology. 2011 Feb;29(4):Abstract Number 86. |
|
| 2004-08-02 |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer |
British Journal of Cancer. 2004 Aug;91(3):453-458. |
|
| 2005 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer |
Oncology. 2005;69(1):88-95. |
|
| 2005-03-28 |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer |
British Journal of Cancer. 2005 Mar;92(6):1013-1018. |
|
| 2000-12 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer |
Lung Cancer. 2000 Dec;30(3):199-202. |
|
| 2003-04 |
Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy |
Journal of the Chinese Medical Association. 2003 Apr;66(4):241-246. |
|
| 2009-12 |
A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma |
Cancer Chemotherapy and Pharmacology. 2009 Dec;65(1):151-157. |
|
| 2006-06 |
A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy |
Lung Cancer. 2006 Jun;52(3):333-338. |
|
| 1998-03 |
Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions |
Respiratory Medicine. 1998 Mar;92(3):473-479. |
|
| 2022-07 |
A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer |
Annals of Oncology. 2022 Jul;33(Suppl. 6):S478. |
|
| 2007-09 |
A phase II trial of oxaliplatin with high-dose of 5-fluorouracil and leucovorin in the first-line treatment of inoperable, locally advanced or metastatic biliary tract cancer |
EJC Supplements. 2007 Sep;5(4):268. |
|
| 2000-02 |
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer |
American Journal of Clinical Oncology. 2000 Feb;23(1):13-17. |
|
| 2005-06 |
A phase II trial of UFUR plus gemcitabine in non-small cell lung cancer patients failing previous platinum-based chemotherapy |
Journal of Clinical Oncology. 2005 Jun;23(16):Abstract number 694S. |
|
| 2000-02 |
A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer |
American Journal of Clinical Oncology. 2000 Feb;23(1):60-64. |
|
| 2003-05 |
A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older |
Lung Cancer. 2003 May;40(2):221-226. |
|
| 2016-05 |
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC) |
Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number 4017. |
|
| 2018-06 |
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma |
Annals of Oncology. 2018 Jun;29(6):1402-1408. |
|
